pharmaceuticals
The latest Carbon Impact report shows rising pressure on suppliers to disclose emissions data, adopt renewable energy, and provide product-level footprints
| 2 min read
US–UK pricing commitments, tariff changes, and investment expectations could influence lab budgets and supply chains
| 2 min read
New My Green Lab briefing highlights measurable emissions reductions, expanding certification programs, and deeper supplier engagement across the life science sector
| 3 min read
Acquisition strengthens Thermo Fisher’s position in digital clinical trials and AI-enabled data analysis for pharma and biotech customers
| 2 min read
Optimize pharma analytical data management & archiving with LIMS. Ensure compliance, integrity, and efficiency in your lab workflows. Get actionable strategies now!
| 5+ min read
Sanofi joins global drugmakers investing in the US in anticipation of pharmaceutical tariffs, which could lead to more American-based lab jobs
| 2 min read
Streamlining pain therapeutic development through advanced ion channel analysis
| 1 min read
With $50 billion committed to R&D and manufacturing, Roche deepens its US footprint, highlighting how life sciences firms are insulating operations against trade disruption
| 2 min read
